Cargando…

“Management of myositis associated interstitial lung disease”

Idiopathic inflammatory myopathies (IIM) are rare disorders characterised by the presence of skeletal muscle inflammation, with interstitial lung disease (ILD) being the most frequent pulmonary manifestation. The spectrum of clinical presentations of myositis related ILD (M-ILD) encompasses a chroni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thong, Lorraine, Chawke, Liam J., Murphy, Grainne, Henry, Michael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185598/ https://www.ncbi.nlm.nih.gov/pubmed/37126103 http://dx.doi.org/10.1007/s00296-023-05336-z

Ejemplares similares

Management of Myositis-Associated Interstitial Lung Disease
por: Fujisawa, Tomoyuki
Publicado: (2021)

Analytic Morphomics in Myositis-Related Interstitial Lung Disease
por: O’Mahony, Alexander T., et al.
Publicado: (2023)

Myositis interstitial lung disease and autoantibodies
por: Chaudhry, Shire, et al.
Publicado: (2023)

Prognostic Factors for Myositis-Associated Interstitial Lung Disease
por: Fujisawa, Tomoyuki, et al.
Publicado: (2014)

High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease
por: Egashira, Ryoko
Publicado: (2021)

Myositis-Related Interstitial Lung Disease: A Respiratory Physician’s Point of View
por: Waseda, Yuko
Publicado: (2021)

Clinical features and outcomes of patients with myositis associated-interstitial lung disease
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Significance of Myositis Autoantibody in Patients with Idiopathic Interstitial Lung Disease
por: Song, Ju Sun, et al.
Publicado: (2015)

Anti Jo-1 myositis. 'Mechanic's hands' and interstitial lung disease.
por: Taggart, A. J., et al.
Publicado: (2002)

In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
por: Chinoy, Hector, et al.
Publicado: (2006)

MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report
por: Alqatari, Safi, et al.
Publicado: (2018)

Assessment of Optimal Screening Tests for the Detection of an Inflammatory Myositis-associated Interstitial Lung Disease
por: Castillo, Sonia, et al.
Publicado: (2020)

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases
por: Moll, Sofia A., et al.
Publicado: (2022)

Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis
por: Vojinovic, Tamara, et al.
Publicado: (2020)

Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
por: Ceribelli, Angela, et al.
Publicado: (2023)

Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study
por: Rivière, Amélie, et al.
Publicado: (2022)

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
por: Baah, Samantha, et al.
Publicado: (2021)

Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases
por: Nurmi, Hanna M., et al.
Publicado: (2023)

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease
por: Moll, Sofia A., et al.
Publicado: (2020)

Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort
por: Chen, Fang, et al.
Publicado: (2022)

Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
por: Misra, Abhinav K., et al.
Publicado: (2021)

Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease
por: Kaieda, Shinjiro, et al.
Publicado: (2020)

Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis
por: Cotton, Thaisa, et al.
Publicado: (2022)

Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease
por: Lee, Hyun, et al.
Publicado: (2022)

Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease
por: Wang, Yukai, et al.
Publicado: (2020)

Diagnosis and management of interstitial lung disease
por: Meyer, Keith C
Publicado: (2014)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
por: Kang, Eun Ha, et al.
Publicado: (2010)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease
por: Koo, So-My, et al.
Publicado: (2019)

Management of Cancer-Associated Myositis
por: Selva-O’Callaghan, Albert, et al.
Publicado: (2022)

Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease
por: Berger, Kristin, et al.
Publicado: (2023)

Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases
por: Castelino, Flavia V., et al.
Publicado: (2021)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Mortality Risk Stratification Using Cluster Analysis in Patients With Myositis-Associated Interstitial Lung Disease Receiving Initial Triple-Combination Therapy
por: Gono, Takahisa, et al.
Publicado: (2022)

State of the art in the diagnosis and management of interstitial lung disease
por: BUZAN, MARIA T. A., et al.
Publicado: (2015)

Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model
por: Cao, Heng, et al.
Publicado: (2020)

Rheumatoid arthritis-associated interstitial lung disease
por: Solomon, Joshua J, et al.
Publicado: (2012)

Investigating Idiopathic Inflammatory Myopathy; Initial Cross Speciality Experience with Use of the Extended Myositis Antibody Panel
por: O'Connor, Antoinette, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ptko2lnos7s0kavpbngtfr155